为了解决这一问题，来自瑞典乌普萨拉大学（Uppsala University）和瑞士美敦力公司（Medtronic）等机构的研究人员展开了一项 ... 研究结果显示，在 20 年的时间跨度内，深部脑刺激（deep brain stimulation，DBS）联合最佳药物治疗（best medical therapy，BMT）是最具成本效益 ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology†, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease.The approval is for ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...

Deep brain stimulation (DBS) has been instrumental in managing Parkinson's symptoms for over three decades. Medtronic's Percept™ DBS neurostimulators now incorporate BrainSense™ Adaptive ...